Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Starpharma.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s Health Powerplays: Biotechs hitting it out of the park
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health Kick Podcast: Starpharma goes from strength to strength following news of progress on COVID-19 nasal spray
Health & Biotech
COVID has opened up potentially lucrative opportunities for these Aussie microcaps
Experts
Scopo’s Health Powerplays: Show me the (grant) money
Health & Biotech
Check up: Health sector slips as earning season ends
Health & Biotech
G Medical to delist from ASX despite a May promise to stay
Health & Biotech
COVID-19 treatments are a better bet than a vaccine
Health & Biotech
Going viral: All the biggest COVID-19 news from the last week
Health & Biotech
Big gains for two ASX pharma stocks as investors stay on the hunt for potential COVID-19 solutions
Health & Biotech
Health: Neuren gets extra FDA push for its treatment for rare Rett disease
Health & Biotech
Here’s how to pick a successful drug out of the 99pc of failures
Health & Biotech
Dr Boreham’s Crucible: Why CSL is the poster child for most junior drug developers
Health & Biotech
Health: Are Uscom’s sales *really* up on coronavirus?
Health & Biotech
9 of the most interesting biotech bosses in the game: part 2
Health & Biotech
